Evid Invest
Who owns ORKAWhat ORKA owns — n/a

Who owns Oruka Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of ORKA from SEC Form 13F filings across 260 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 260 institutions disclosed 76.7M shares of Oruka Therapeutics, Inc. worth $6.43B — about 122.1% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

260

13F holders

$6.43B

value, 2026 filers

122.1%

of shares outstanding (76.7M sh)

42

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of ORKA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC10.1M$845.3M0.0%16.1%+12.0%
2BlackRock, Inc.5.2M$434.0M0.0%8.3%+4.4%
3T. Rowe Price Investment Management, Inc.4.4M$365.8M0.3%7%+297.9%
4Venrock Adviser, LLC4.1M$345.5M16.8%6.6%0.0%
5Fairmount Funds Management LLC3.7M$308.6M19.4%5.9%0.0%
6Capital World Investors3.4M$285.6M0.0%5.5%+0.8%
7RTW INVESTMENTS, LP3.1M$261.4M2.6%5%0.0%
8STATE STREET CORP2.8M$234.6M0.0%4.5%+5.4%
9VANGUARD CAPITAL MANAGEMENT LLC2.6M$220.2M0.0%4.2%+12.0%
10Paradigm Biocapital Advisors LP2.5M$207.7M4.1%4%+16.3%
11FRANKLIN TEMPLETON INC2.0M$206.2M0.0%3.2%+25.4%
12Janus Henderson Group Ltd.NEW1.9M$156.0M0.1%3%new
13Bellevue Group AG1.6M$136.7M2.8%2.6%-1.0%
14VANGUARD PORTFOLIO MANAGEMENT LLC1.6M$132.6M0.0%2.5%+173.4%
15RA CAPITAL MANAGEMENT, L.P.1.6M$129.5M1.3%2.5%0.0%
16GEODE CAPITAL MANAGEMENT, LLC1.5M$128.7M0.0%2.5%+8.1%
17Polar Capital Holdings Plc1.2M$102.0M0.2%1.9%-0.3%
18PERCEPTIVE ADVISORS LLC1.1M$89.3M1.6%1.7%-20.3%
19Deep Track Capital, LP1.1M$89.1M1.5%1.7%-44.5%
20PRICE T ROWE ASSOCIATES INC /MD/966,767$80.5M0.0%1.5%+15.3%
21Remedium Capital Partners, LLC954,150$79.5M29.0%1.5%-39.1%
22WESTFIELD CAPITAL MANAGEMENT CO LP829,749$69.1M0.2%1.3%+31.4%
23Avidity Partners Management LP785,424$65.4M13.4%1.2%+3.3%
24SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC723,922$60.3M1.1%1.2%+10.0%
25JPMORGAN CHASE & CO695,630$57.4M0.0%1.1%+6.2%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.